J&J Vaccine Gets Reapproval After Review Of ‘Extremely Rare’ Blood Clots

Published Date: 4/23/2021

Source: huffpost.com

A rare side effect, seen by 1.9 people per million doses given, had forced the CDC and FDA to pause distribution.